Propranolol

Back to search

Molecule Structure

Scientific Name

Propranolol

Description of the Drug

Propranolol is a non-selective beta adrenergic antagonist used to treat hypertension, angina, atrial fibrillation, myocardial infarction, migraine, essential tremor, hypertrophic subaortic stenosis, and pheochromocytoma.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00571

Brand Name(s)

Not Available

Company Owner(s)

Pierre Fabre Dermatologie, Dava Pharmaceuticals Inc, Schering Corp Sub Schering Plough Corp, Solopak Medical Products Inc, Watson Laboratories Inc, Duramed Pharmaceuticals Inc Sub Barr Laboratories Inc, Mylan Pharmaceuticals Inc, Purepac Pharmaceutical Co, Impax Laboratories Inc, Zydus Pharmaceuticals Usa Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Beta-1 adrenergic receptor SINGLE PROTEIN ANTAGONIST CHEMBL213
Beta-2 adrenergic receptor SINGLE PROTEIN ANTAGONIST CHEMBL210

Unichem Links

SureChEMBL SCHEMBL3955
PharmGKB PA451145
Human Metabolome Database HMDB0001849
DrugBank DB00571
PubChem: Thomson Pharma 14823711
PubChem 4946
Mcule MCULE-7804628650
NMRShiftDB 60025561
LINCS LSM-4329
Nikkaji J6.653B
BindingDB 25761
EPA CompTox Dashboard DTXSID6023525
DrugCentral 2303
Metabolights MTBLC8499
Brenda 5606 66047 45500 3905
ChemicalBook CB63039539 CB0875381
Guide to Pharmacology 564
rxnorm INDERAL PROPRANOLOL HYDROCHLORIDE INNOPRAN HEMANGEOL PROPRANOLOL
KEGG Ligand C07407
ChEBI 8499